Use Biopath Holdings Inc management performance together with your portfolio for risky short term speculation or day-trading and to determine OTC Equity optimization strategy that fits your criteria.
Biopath Management Effectiveness
The company has return on total asset (ROA) of (40.84) % which means that it has lost $40.84 on every $1 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (82.84) % meaning that it generated substantial loss on money invested by shareholders.
Biopath Insiders
Peter Nielsen Co-Founder, Chairman, CEO and President CFO, Chief Accounting Officer and Treasurer, MBA
Douglas Morris Co-Founder, VP of Corporate Devel., Secretary, Director and Member of Compensation Committee
Biopath Holdings Inc is rated below average in number of employees category among related companies. The total workforce of Drug Delivery industry is currently estimated at about 23,623. Biopath adds roughly 2.0 in number of employees claiming only tiny portion of equities under Drug Delivery industry.
Co-Founder, Chairman, CEO and President CFO, Chief Accounting Officer and Treasurer
Mr. Peter Henry Nielsen is Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Treasurer of BioPath Holdings Inc. He is a cofounder of BioPath, serving as its Chief Executive Officer, Pres...
Biopath employes about 2 people. The company is managed by 6 executives with total tenure of roughly 4 years, averanging almost 0.0 years of service per executive having 0.0 employee per reported executive.
Return on Biopath Manpower
Net Loss Per Employee
1.1 M
Net Loss Per Executive
381.7 K
Working Capital Per Employee
203.5 K
Working Capital Per Executive
67.8 K
Biopath Earnings Per Share
According to company disclosure Biopath Holdings Inc has Earnings Per Share of -0.04 times. This is 103.77% lower than that of Healthcare sector, and 107.69% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 102.67% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
Management
Discussion
